Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer

P. S. Venkat; R. Shridhar; A. O. Naghavi; S. E. Hoffe; K. Almhanna; J. M. Pimiento; J.-P. Fontaine; Y. Abuodeh; K. L. Meredith; J. M. Frakes

doi:10.1093/dote/dox036

journal article May 19, 2017

Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer

P. S. Venkat R. Shridhar A. O. Naghavi S. E. Hoffe K. Almhanna J. M. Pimiento J.-P. Fontaine Y. Abuodeh K. L. Meredith J. M. Frakes

Diseases of the Esophagus Vol. 30 No. 7 pp. 1-9 · Oxford University Press (OUP)

View at Publisher Save 10.1093/dote/dox036

Topics

No keywords indexed for this article. Browse by subject →

References

25

[1]

"Global cancer statistics" CA Cancer J Clin (2011) 10.3322/caac.20107

[2]

"Cancer statistics, 2014" CA Cancer J Clin (2014) 10.3322/caac.21208

[3]

"Radiation therapy and esophageal cancer" Cancer Control (2013) 10.1177/107327481302000203

[4]

"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis" Lancet Oncol (2011) 10.1016/s1470-2045(11)70142-5

[5]

"Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial" Lancet Oncol (2005) 10.1016/s1470-2045(05)70288-6

[6]

"A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma" Ann Oncol (2004) 10.1093/annonc/mdh219

[7]

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

Joel Tepper, Mark J. Krasna, Donna Niedzwiecki et al.

Journal of Clinical Oncology 2008 10.1200/jco.2007.12.9593

[8]

"Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma" J Clin Oncol (2001) 10.1200/jco.2001.19.2.305

[9]

"Preoperative chemoradiotherapy for esophageal or junctional cancer" N Engl J Med (2013)

[10]

"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma" N Engl J Med (1996) 10.1056/nejm199608153350702

[11]

"Multimodality treatment with intensity modulated radiation therapy for esophageal cancer" Dis Esophagus (2010)

[12]

"Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer" World J Gastroenterol (2006) 10.3748/wjg.v12.i34.5501

[13]

"Intensity-modulated or 3-D conformal radiotherapy combined with chemotherapy with docetaxel and cisplatin for locally advanced esophageal carcinoma" Nan Fang Yi Ke Da Xue Xue Bao (2011)

[14]

"Outcomes of definitive or preoperative IMRT chemoradiation for esophageal cancer" J Radiat Oncol (2012) 10.1007/s13566-012-0048-5

[15]

"Comparative outcomes for three-dimensional conformal versus intensity-modulated radiation therapy for esophageal cancer" Dis Esophagus (2014)

[16]

"Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer" Int J Radiat Oncol Biol Phys (2012) 10.1016/j.ijrobp.2012.02.015

[17]

"Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal cancer" J Gastrointest Oncol (2015)

[18]

"Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy" Pract Radiat Oncol (2013) 10.1016/j.prro.2012.02.006

[19]

Pathological response following long‐course neoadjuvant chemoradiotherapy for locally advanced rectal cancer

R Ryan, D Gibbons, J M P Hyland et al.

Histopathology 2005 10.1111/j.1365-2559.2005.02176.x

[20]

"Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial" J Clin Oncol (1999) 10.1200/jco.1999.17.8.2396

[21]

"Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01)" JAMA (1999)

[22]

INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

Bruce D. Minsky, Thomas F. Pajak, Robert J. Ginsberg et al.

Journal of Clinical Oncology 2002 10.1200/jco.2002.20.5.1167

[23]

"Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma: early results of a phase II study" Strahlenther Onkol (2014) 10.1007/s00066-014-0636-y

[24]

Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

Laurent Bedenne, Pierre Michel, Olivier Bouché et al.

Journal of Clinical Oncology 2007 10.1200/jco.2005.04.7118

[25]

Chemoradiation With and Without Surgery in Patients With Locally Advanced Squamous Cell Carcinoma of the Esophagus

Michael Stahl, Martin Stuschke, Nils Lehmann et al.

Journal of Clinical Oncology 2005 10.1200/jco.2005.00.034

Cited By

17

Phase II randomized trial of 41.4 Gy vs. 50.4 Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancer

Ebrahim Esmati, Reza Nazari · 2026

Clinical and Translational Radiatio...

Metrics

17

Citations

25

References

Details

Published: May 19, 2017
Vol/Issue: 30(7)
Pages: 1-9

Authors

Cite This Article

P. S. Venkat, R. Shridhar, A. O. Naghavi, et al. (2017). Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer. Diseases of the Esophagus, 30(7), 1-9. https://doi.org/10.1093/dote/dox036

Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer

You May Also Like